Group Genome Instability in Tumors, DKFZ, Heidelberg, Germany.
Division of Molecular Genetics, DKFZ, Heidelberg, Germany.
Nat Commun. 2020 May 8;11(1):2320. doi: 10.1038/s41467-020-16134-7.
Chromothripsis is a recently identified mutational phenomenon, by which a presumably single catastrophic event generates extensive genomic rearrangements of one or a few chromosome(s). Considered as an early event in tumour development, this form of genome instability plays a prominent role in tumour onset. Chromothripsis prevalence might have been underestimated when using low-resolution methods, and pan-cancer studies based on sequencing are rare. Here we analyse chromothripsis in 28 tumour types covering all major adult cancers (634 tumours, 316 whole-genome and 318 whole-exome sequences). We show that chromothripsis affects a substantial proportion of human cancers, with a prevalence of 49% across all cases. Chromothripsis generates entity-specific genomic alterations driving tumour development, including clinically relevant druggable fusions. Chromothripsis is linked with specific telomere patterns and univocal mutational signatures in distinct tumour entities. Longitudinal analysis of chromothriptic patterns in 24 matched tumour pairs reveals insights in the clonal evolution of tumours with chromothripsis.
染色体重排是一种最近被发现的突变现象,其导致一个或几个染色体发生广泛的基因组重排。这种形式的基因组不稳定性被认为是肿瘤发生早期的一个重要事件,在肿瘤的发生中起着突出的作用。当使用低分辨率方法时,染色体重排的流行率可能被低估了,并且基于测序的泛癌症研究很少。在这里,我们分析了 28 种肿瘤类型中的染色体重排,涵盖了所有主要的成人癌症(634 个肿瘤,316 个全基因组和 318 个全外显子组序列)。我们表明,染色体重排影响了相当一部分人类癌症,所有病例的流行率为 49%。染色体重排产生了实体特异性的基因组改变,推动了肿瘤的发展,包括临床上相关的可用药融合。染色体重排与特定的端粒模式和不同肿瘤实体中独特的突变特征有关。对 24 对匹配肿瘤的染色体重排模式进行纵向分析,揭示了具有染色体重排的肿瘤克隆进化的一些见解。